Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 26;56(5):2003276.
doi: 10.1183/13993003.03276-2020. Print 2020 Nov.

Patient-reported outcome measures after COVID-19: a prospective cohort study

Alyson W Wong  1   2   3 , Aditi S Shah  1   3 , James C Johnston  1   4   5   3 , Christopher Carlsten  1   4   3 , Christopher J Ryerson  1   2   3
Affiliations

Patient-reported outcome measures after COVID-19: a prospective cohort study

Alyson W Wong et al. Eur Respir J. .

Abstract

Over 75% of patients admitted to hospital with COVID-19 have abnormal patient-reported outcome measures 3 months after symptom onset, with a third of patients reporting at least moderate impairment in major dimensions of quality of life https://bit.ly/32QMMgw

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: A.S. Shah has nothing to disclose. Conflict of interest: J.C. Johnston has nothing to disclose. Conflict of interest: C. Carlsten has nothing to disclose. Conflict of interest: C.J. Ryerson has nothing to disclose. Conflict of interest: A.W. Wong has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
a) Patient reported outcomes 3 months after coronavirus disease 2019 (COVID-19) symptom onset stratified by the presence (red) or absence (blue) of Charlson comorbidities. Each circle represents a patient and the box represents the median and interquartile range. The y-axis shows the complete range of possible scores, and areas shaded in grey represent the normal range based on population adjusted norms where available. The provided normal threshold for dyspnoea is based on double the value of the minimum clinically important difference given the absence of an established normal range. b) Percentage of patients with impairment in each dimension of the 5-level EuroQoL 5-Dimensions (EQ-5D-5L). Results are shown for the total cohort (grey), and stratified by the presence (red) or absence (blue) of pre-existing Charlson comorbidities. Each dimension has five levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Patients who reported moderate problems or worse for a given dimension were considered to have impairment. PHQ: Patient Health Questionnaire; PSQI: Pittsburgh Sleep Quality Index; UCSD: University of California San Diego Shortness of Breath Questionnaire; VAS: Visual Analog Scale.
See this image and copyright information in PMC

Similar articles

  • Development of maculopapular exanthem in a COVID-19 patient.
    Motohashi I, Takano T, Ie K, Hashimoto Y, Akino S, Okuse C. Motohashi I, et al. J Dermatol. 2020 Dec;47(12):e426-e427. doi: 10.1111/1346-8138.15579. Epub 2020 Aug 29. J Dermatol. 2020. PMID: 32860276 No abstract available.
  • Skin manifestations in COVID-19: The tropics experience.
    Rerknimitr P, Theerawattanawit C, Lertpichitkul P, Jantarabenjakul W, Putcharoen O, Puthanakit T, Panchaprateep R, Kumtornrut C, Asawanonda P. Rerknimitr P, et al. J Dermatol. 2020 Dec;47(12):e444-e446. doi: 10.1111/1346-8138.15567. Epub 2020 Sep 2. J Dermatol. 2020. PMID: 32881043 No abstract available.
  • Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infection.
    Darley DR, Dore GJ, Cysique L, Wilhelm KA, Andresen D, Tonga K, Stone E, Byrne A, Plit M, Masters J, Tang H, Brew B, Cunningham P, Kelleher A, Matthews GV. Darley DR, et al. Med J Aust. 2021 Apr;214(6):279-280. doi: 10.5694/mja2.50963. Epub 2021 Mar 3. Med J Aust. 2021. PMID: 33657671 Free PMC article. No abstract available.
  • Innovation in Cancer Care Delivery in the Era of COVID-19.
    Mullangi S, Schleicher SM, Aviki EM. Mullangi S, et al. JCO Oncol Pract. 2020 Nov;16(11):718-719. doi: 10.1200/OP.20.00336. Epub 2020 Jun 17. JCO Oncol Pract. 2020. PMID: 32552318 No abstract available.
  • Abordaje hemodinámico y ventilatorio en pacientes con COVID-19.
    Carrillo-Esper R, Mejía-Gómez L, Monares-Zepeda E, Chavarría-Martínez U, Díaz-Carrillo A, Ayala-León M, Zamora-Gómez S, Sánchez-Díaz JS, Lomelí-Terán M, Briones-Garduño JC, Pérez-Calatayud ÁA. Carrillo-Esper R, et al. Cir Cir. 2020;88(6):805-817. doi: 10.24875/CIRU.20000301. Cir Cir. 2020. PMID: 33254199 Review. English.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Canadian Institute for Health Information Patient-reported Outcome Measures (PROMs). www.cihi.ca/en/patient-reported-outcome-measures-proms Date last accessed: 24 August 2020.
    1. Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–1062. doi:10.1016/S0140-6736(20)30566-3 - DOI - PMC - PubMed
    1. Carfi A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603–605. doi:10.1001/jama.2020.12603 - DOI - PMC - PubMed
    1. Vancouver Coastal Health Who We Serve www.vch.ca/about-us/who-we-serve Date last accessed: 24 Aug 2020.
    1. Buysse D, Reynolds C III, Monk T, et al. . The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1988; 28: 193–213. doi:10.1016/0165-1781(89)90047-4 - DOI - PubMed